Insider trades
Thomas Leggett, CFO of Stoke Therapeutics STOK, has filed 0 purchases and 5 sales on the open market. Over the past 12 months that comes to a net sale of $147.1K. The latest trade was on 03/18.
Thomas Leggett
CFO
- Company
- Stoke Therapeutics STOK
- First filing
- 24/05/17
- Trades
- 12 trades
- Buys / sales
- 0 / 5
- 12-month net buying
- −$147.1K
- Last trade
- 03/18